Posts

Showing posts with the label Genetic Toxicology Testing Market Share

Genetic Toxicology Testing Market Size Poised To Reach USD 3.57 Billion By 2030

Image
  San Francisco, 19 Sep 2024:  The Report  Genetic Toxicology Testing Market  Size, Share & Trends Analysis Report By Vehicle Type (Passenger, LCV, HCV), By Application (Engine, Chassis, Interior), By Region, And Segment Forecasts, 2024 - 2030 The global genetic toxicology testing market size is anticipated to reach USD 3.57 billion by 2030, registering to grow at a CAGR of 11.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product. Increasing implementation of pharmacogenomics...

Genetic Toxicology Testing Market Is Expected To Reach $ 3.57 Billion By 2030

Image
  San Francisco, 12 Aug 2023:  The Report  Genetic Toxicology Testing Market  Size, Share & Trends Analysis Report By Type (In-vitro, In-vivo), By Product (Reagents & Consumables, Assays, Services), By Application, By Region, And Segment Forecasts, 2022 - 2030 The global genetic toxicology testing market size is expected to reach USD 3.57 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 12.7% from 2022 to 2030. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product. Increasing ...